-- 加拿大獨立企業聯合會 (CFIB) 的一項最新研究顯示，加拿大連續六個季度倒閉的企業數量超過新開業的企業數量，超過一半 (55%) 的小企業主表示，他們現在不會建議別人創業。 CFIB 在周三發布的一份報告中指出，自 2024 年初以來，加拿大一直處於創業“低迷期”，即企業倒閉數量持續超過新企業成立數量。 CFIB 補充道，高昂的成本、繁文縟節和勞動力短缺等問題阻礙了新一代企業家的創業熱情，因此，扭轉加拿大的創業低迷局面必須被視為國家經濟的優先事項。 CFIB 草原和北部地區主管 Brianna Solberg 表示：“我們不能讓經濟中的雄心壯志被監管扼殺。當超過半數的小企業主告訴你他們不會建議別人創業時，我們就應該認真聽取他們的意見。”
Related Articles
Asia
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
$HKG:0895$SHE:002672
Sectors
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.
$HKG:6866